Author:
Tishchenko V K,Petriev V M,Stepchenkova E D,Shegai P V,Ivanov S A,Kaprin A D
Abstract
Abstract
Bone metastases are serious complication in the progression of various types of cancer. It determines the requirement of modern nuclear diagnostic tools, including positron emission tomography (PET). In this study the biodistribution of EDTMP labeled with gallium-68 (68Ga-EDTMP) prepared at different temperature (20, 50, and 95 °C) was investigated. All experimental studies were performed in healthy intact Wistar rats by measuring the radioactivity in organs and tissues with gamma counter. All 68Ga-EDTMP formulations accumulated predominantly in bones. Only in tibia the uptake of 68Ga-EDTMP prepared at 95 °C was higher (p < 0.05) than 68Ga-EDTMP prepared at 20 °C, but in other bones there weren’t any statistical differences in uptake of 68Ga-EDTMP formulations. The amounts of 68Ga-EDTMP formulations in soft organs and tissues were lower when compared with bones. In conclusion, a temperature of reaction mixture had an influence on the biodistribution of 68Ga-EDTMP in bones.
Subject
General Physics and Astronomy
Reference7 articles.
1. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging;Suzuki;Nucl. Med. Biol.,2011
2. Preparation, Characterization, and Radiolabeling of [68Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent;Ashhar;Molecules,2020
3. Bone- seeking radiopharmaceuticals based on phosphonic acids and 68Ga (review);Tishchenko;Radiation and Risk,2020
4. Preperation and pre-vivo evaluation of no-carrier-added, carrier-added and cross-complexed [68Ga]-EDTMP formulations;Toegel;Eur. J. Pharm. Biopharm.,2008
5. Pharmacokinetic properties of a new bone-seeking compound based on N,N,N',N'- ethylenediaminetetrakis(methylene phosphonic acid) labeled with 68Ga in intact rats and rats with experimental model of bone callus;Tishchenko;Radiation and Risk,2019